InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ordonez Claudia, Directeur Médical. Officer active across 1 companies, notably Keros Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. The latest transaction was disclosed on 11 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€3941,000 shares@ €0.39430.0001% mcap49.9% of flow
Common Stock
SEC:0001209191-21-040648·
€3941,000 shares@ €0.39430.0001% mcap25.0% of flow
Common Stock
SEC:0001209191-21-040648:0·
€3951,000 shares@ €0.39520.0001% mcap50.1% of flow
Common Stock
SEC:0001209191-21-032361·
€3951,000 shares@ €0.39520.0001% mcap25.0% of flow
Common Stock
SEC:0001209191-21-032361:0·
4 of 4 declarations
About Ordonez Claudia
Claudia Ordonez is Chief Medical Officer at Keros Therapeutics, Inc., a biopharmaceutical company. She is responsible for medical strategies and clinical operations. Her expertise in medicine and research is essential for the development of new treatments.
